Skip to main content
. Author manuscript; available in PMC: 2017 Oct 23.
Published in final edited form as: Crit Rev Biomed Eng. 2009;37(4-5):321–353. doi: 10.1615/critrevbiomedeng.v37.i4-5.20

TABLE 1.

List of Neurodegenerative Diseases That Can Be Impacted by Cell-and/or Gene-Based Therapies

Disease Underlying Cause Potential Treatment Strategy
PD Death of dopaminergic neurons Transplantation of dopaminergic neurons derived from ESC/iPS cells
Stroke Neuronal death Cell replacement with fully functional neurons derived from ESC/iPS cells
ALS Loss of motor neurons Cell therapy based on motor neurons derived from ESC/iPS cells
SMA Spinal motor neuron death Drug screening based on in vitro models of NPs/iPS cells for SMA; generation of spinal motor neurons from iPS cells
HD Death of neurons in the striatum Cell replacement with striatal neurons derived from iPS cells
AD Loss of neurons and synapses throughout the brain Drug screening based on in vitro models of AD; gene and cell therapy: transplantation of cells that overexpress NGF
MS Immune system attacking myelin sheaths Cell therapy based on transplantation of oligodendrocytes derived from ESC/iPS cells; autologous stem cell transplantation to repopulate the immune system

iPS, induced pluripotent stem